CVS Health entered the second quarter of 2025 with a clear strategy to simplify healthcare and connect insurance, pharmacy and care services. Organic growth across all segments supported sales, while management adjusted full-year guidance upward for both adjusted earnings per share and operating cash. The company also announced acquisitions in retail and several management changes to accelerate operational and technology initiatives.

Meanwhile, one-time legal costs were an important theme of the quarter, weighing on accounting earnings below GAAP and increasing the effective tax rate. However, underlying operating performance remained solid: Aetna (Health Care Benefits) was clearly up, CVS Pharmacy grew in revenue and volume, and CVS Caremark (Health Services/PBM) managed a more challenging pricing environment supported by improved purchasing conditions.

How was the most recent quarter?

In the second quarter, $CVSsales rose to $98.9 billion, up 8.4% from a year ago, with all three major…